Rank | Gene Set | Z-score |
---|---|---|
1 | microglial cell activation (GO:0001774) | 7.19623130 |
2 | modulation by symbiont of host immune response (GO:0052553) | 6.46148681 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.46148681 |
4 | modulation by symbiont of host defense response (GO:0052031) | 6.46148681 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.46148681 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.46148681 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.46148681 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.12203108 |
9 | positive regulation of chemokine secretion (GO:0090197) | 6.11839325 |
10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.58792674 |
11 | macrophage activation involved in immune response (GO:0002281) | 5.51082041 |
12 | limb bud formation (GO:0060174) | 5.05894695 |
13 | mitotic sister chromatid cohesion (GO:0007064) | 5.02467890 |
14 | regulation of chemokine secretion (GO:0090196) | 4.99791978 |
15 | nuclear pore complex assembly (GO:0051292) | 4.95741182 |
16 | negative regulation of granulocyte differentiation (GO:0030853) | 4.89530365 |
17 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.77215958 |
18 | I-kappaB phosphorylation (GO:0007252) | 4.35554467 |
19 | nuclear pore organization (GO:0006999) | 4.29619245 |
20 | chromatin remodeling at centromere (GO:0031055) | 4.22613262 |
21 | response to host (GO:0075136) | 4.21097324 |
22 | response to host defenses (GO:0052200) | 4.21097324 |
23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.21097324 |
24 | macrophage activation (GO:0042116) | 4.20161050 |
25 | response to host immune response (GO:0052572) | 4.20090728 |
26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.20090728 |
27 | CENP-A containing nucleosome assembly (GO:0034080) | 4.17413048 |
28 | metaphase plate congression (GO:0051310) | 4.07820224 |
29 | regulation of centriole replication (GO:0046599) | 3.92543728 |
30 | histone exchange (GO:0043486) | 3.91684094 |
31 | keratan sulfate catabolic process (GO:0042340) | 3.85009381 |
32 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.80546856 |
33 | establishment of chromosome localization (GO:0051303) | 3.76719754 |
34 | establishment of nucleus localization (GO:0040023) | 3.72966617 |
35 | mitotic metaphase plate congression (GO:0007080) | 3.67631945 |
36 | neural tube formation (GO:0001841) | 3.62733529 |
37 | dorsal/ventral axis specification (GO:0009950) | 3.60715620 |
38 | positive regulation of interferon-alpha production (GO:0032727) | 3.58789758 |
39 | pore complex assembly (GO:0046931) | 3.51700212 |
40 | regulation of sister chromatid cohesion (GO:0007063) | 3.51366150 |
41 | kinetochore organization (GO:0051383) | 3.45474063 |
42 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.38626645 |
43 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.38153306 |
44 | regulation of interferon-alpha production (GO:0032647) | 3.36013664 |
45 | DNA double-strand break processing (GO:0000729) | 3.34493689 |
46 | non-recombinational repair (GO:0000726) | 3.33751579 |
47 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.33751579 |
48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.32798939 |
49 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.31611276 |
50 | mitotic G2/M transition checkpoint (GO:0044818) | 3.30469147 |
51 | hyaluronan catabolic process (GO:0030214) | 3.30222975 |
52 | negative regulation of axon guidance (GO:1902668) | 3.26885756 |
53 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.26023232 |
54 | olfactory bulb development (GO:0021772) | 3.24877033 |
55 | sister chromatid segregation (GO:0000819) | 3.24553396 |
56 | sister chromatid cohesion (GO:0007062) | 3.24165876 |
57 | spindle checkpoint (GO:0031577) | 3.21661374 |
58 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.21387965 |
59 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.20428173 |
60 | DNA replication-independent nucleosome organization (GO:0034724) | 3.19504757 |
61 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.19504757 |
62 | negative regulation of DNA repair (GO:0045738) | 3.19382418 |
63 | monocyte differentiation (GO:0030224) | 3.18939262 |
64 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.15504532 |
65 | pre-miRNA processing (GO:0031054) | 3.13237063 |
66 | replication fork processing (GO:0031297) | 3.12492101 |
67 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.11219747 |
68 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.10206037 |
69 | cellular extravasation (GO:0045123) | 3.08950433 |
70 | positive regulation of antigen processing and presentation (GO:0002579) | 3.06311955 |
71 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.03515521 |
72 | oligosaccharide catabolic process (GO:0009313) | 3.02896367 |
73 | kinetochore assembly (GO:0051382) | 3.00369882 |
74 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.99746014 |
75 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.99746014 |
76 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.99746014 |
77 | protein prenylation (GO:0018342) | 2.99506899 |
78 | prenylation (GO:0097354) | 2.99506899 |
79 | negative regulation of DNA recombination (GO:0045910) | 2.98023907 |
80 | apoptotic cell clearance (GO:0043277) | 2.97862853 |
81 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.94311892 |
82 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.94231676 |
83 | positive regulation of B cell differentiation (GO:0045579) | 2.94143852 |
84 | substrate-dependent cell migration (GO:0006929) | 2.94067548 |
85 | mitotic spindle checkpoint (GO:0071174) | 2.92709969 |
86 | gastrulation with mouth forming second (GO:0001702) | 2.92290002 |
87 | genitalia morphogenesis (GO:0035112) | 2.91639133 |
88 | regulation of chromosome segregation (GO:0051983) | 2.91370085 |
89 | regulation of Rac protein signal transduction (GO:0035020) | 2.90855340 |
90 | ruffle organization (GO:0031529) | 2.89501308 |
91 | cerebral cortex cell migration (GO:0021795) | 2.86320183 |
92 | positive regulation of protein autophosphorylation (GO:0031954) | 2.85851820 |
93 | negative chemotaxis (GO:0050919) | 2.84738109 |
94 | glycosphingolipid catabolic process (GO:0046479) | 2.83972962 |
95 | regulation of centrosome duplication (GO:0010824) | 2.83653383 |
96 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.83420530 |
97 | negative regulation of B cell proliferation (GO:0030889) | 2.83062650 |
98 | DNA ligation (GO:0006266) | 2.82160680 |
99 | macrophage differentiation (GO:0030225) | 2.81938714 |
100 | positive regulation of chemokine production (GO:0032722) | 2.81784105 |
101 | regulation of DNA endoreduplication (GO:0032875) | 2.81773829 |
102 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.80558859 |
103 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.80558859 |
104 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.80553732 |
105 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.80553732 |
106 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.80553732 |
107 | response to muramyl dipeptide (GO:0032495) | 2.80164712 |
108 | negative regulation of tissue remodeling (GO:0034104) | 2.78718891 |
109 | response to X-ray (GO:0010165) | 2.78337266 |
110 | paraxial mesoderm development (GO:0048339) | 2.77475028 |
111 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.77047209 |
112 | negative regulation of bone resorption (GO:0045779) | 2.76382531 |
113 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.76254231 |
114 | chondroitin sulfate catabolic process (GO:0030207) | 2.76171428 |
115 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.73626774 |
116 | protein localization to kinetochore (GO:0034501) | 2.73465712 |
117 | ventricular cardiac muscle cell development (GO:0055015) | 2.72495827 |
118 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.72316877 |
119 | phagocytosis, engulfment (GO:0006911) | 2.68793920 |
120 | regulation of centrosome cycle (GO:0046605) | 2.68158331 |
121 | kidney morphogenesis (GO:0060993) | 2.68011130 |
122 | regulation of collateral sprouting (GO:0048670) | 2.67048979 |
123 | regulation of T cell tolerance induction (GO:0002664) | 2.66487561 |
124 | B cell homeostasis (GO:0001782) | 2.66406148 |
125 | mitotic sister chromatid segregation (GO:0000070) | 2.65416407 |
126 | resolution of meiotic recombination intermediates (GO:0000712) | 2.65414750 |
127 | hindbrain development (GO:0030902) | 2.64943028 |
128 | somite development (GO:0061053) | 2.64437140 |
129 | myeloid cell activation involved in immune response (GO:0002275) | 2.64296065 |
130 | positive regulation of interferon-beta production (GO:0032728) | 2.64252197 |
131 | osteoclast differentiation (GO:0030316) | 2.64174514 |
132 | myelin assembly (GO:0032288) | 2.64014921 |
133 | NLS-bearing protein import into nucleus (GO:0006607) | 2.63830051 |
134 | morphogenesis of an epithelial sheet (GO:0002011) | 2.62515421 |
135 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.61522179 |
136 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.61522179 |
137 | regulation of sister chromatid segregation (GO:0033045) | 2.61522179 |
138 | keratinocyte development (GO:0003334) | 2.60679023 |
139 | lateral sprouting from an epithelium (GO:0060601) | 2.56875136 |
140 | regulation of axon guidance (GO:1902667) | 2.56743834 |
141 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.56717869 |
142 | positive regulation of chromosome segregation (GO:0051984) | 2.55938427 |
143 | female gonad development (GO:0008585) | 2.55810986 |
144 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.54159413 |
145 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.53355762 |
146 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.53355762 |
147 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.53355762 |
148 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.53355762 |
149 | negative regulation of sister chromatid segregation (GO:0033046) | 2.53355762 |
150 | negative regulation of cell killing (GO:0031342) | 2.52631662 |
151 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.52631662 |
152 | midgut development (GO:0007494) | 2.51564423 |
153 | purinergic receptor signaling pathway (GO:0035587) | 2.51372166 |
154 | response to laminar fluid shear stress (GO:0034616) | 2.51306999 |
155 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.50904039 |
156 | negative regulation of bone remodeling (GO:0046851) | 2.50838109 |
157 | cell proliferation involved in metanephros development (GO:0072203) | 2.50680865 |
158 | neutrophil activation involved in immune response (GO:0002283) | 2.50470226 |
159 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.49209587 |
160 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.49142684 |
161 | anterior/posterior axis specification (GO:0009948) | 2.48993276 |
162 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.48766681 |
163 | glycolipid catabolic process (GO:0019377) | 2.48737616 |
164 | cell adhesion mediated by integrin (GO:0033627) | 2.46718245 |
165 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.46621805 |
166 | response to peptidoglycan (GO:0032494) | 2.45875480 |
167 | tolerance induction (GO:0002507) | 2.45247343 |
168 | immunoglobulin mediated immune response (GO:0016064) | 2.43485171 |
169 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42418647 |
170 | regulation of granulocyte differentiation (GO:0030852) | 2.41044496 |
171 | negative regulation of osteoclast differentiation (GO:0045671) | 2.38971340 |
172 | cortical actin cytoskeleton organization (GO:0030866) | 2.36959574 |
173 | regulation of antigen processing and presentation (GO:0002577) | 2.33114860 |
174 | regulation of monocyte differentiation (GO:0045655) | 2.33087044 |
175 | regulation of mast cell degranulation (GO:0043304) | 2.32880741 |
176 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.32664177 |
177 | positive regulation of leukocyte degranulation (GO:0043302) | 2.31511835 |
178 | response to fluid shear stress (GO:0034405) | 2.30579800 |
179 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.28962773 |
180 | negative regulation of interleukin-6 production (GO:0032715) | 2.28451880 |
181 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.28141580 |
182 | axon extension involved in axon guidance (GO:0048846) | 2.28141580 |
183 | myeloid leukocyte activation (GO:0002274) | 2.28009429 |
184 | outer ear morphogenesis (GO:0042473) | 2.27608515 |
185 | regulation of bone resorption (GO:0045124) | 2.27483292 |
186 | negative regulation of interleukin-12 production (GO:0032695) | 2.24284168 |
187 | neutrophil activation (GO:0042119) | 2.23711688 |
188 | regulation of bone remodeling (GO:0046850) | 2.22392781 |
189 | detection of molecule of bacterial origin (GO:0032490) | 2.21687314 |
190 | ceramide catabolic process (GO:0046514) | 2.21370113 |
191 | response to lipoprotein particle (GO:0055094) | 2.20225436 |
192 | receptor catabolic process (GO:0032801) | 2.18440445 |
193 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.18034287 |
194 | positive regulation of mast cell degranulation (GO:0043306) | 2.18034287 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.08208659 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.48997601 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.08963364 |
4 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.04203230 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.03148433 |
6 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.95992053 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.74293528 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.69095690 |
9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.31351462 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.20979713 |
11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04107234 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01340688 |
13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.82680337 |
14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.71799031 |
15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.61826472 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40965956 |
17 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.33789146 |
18 | EWS_26573619_Chip-Seq_HEK293_Human | 2.33190349 |
19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.32950064 |
20 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.32213357 |
21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.29910837 |
22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29713124 |
23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.19784049 |
24 | P300_19829295_ChIP-Seq_ESCs_Human | 2.18570199 |
25 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.16509538 |
26 | FUS_26573619_Chip-Seq_HEK293_Human | 2.06828358 |
27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02690826 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97542734 |
29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96303706 |
30 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.94589902 |
31 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.94266420 |
32 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90573522 |
33 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88796863 |
34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87109031 |
35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.86081390 |
36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83982749 |
37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82599936 |
38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80965985 |
39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.79336566 |
40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.78954209 |
41 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.78321325 |
42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77986293 |
43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76369021 |
44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74997856 |
45 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.71690158 |
46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.66581268 |
47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.66081948 |
48 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.65389967 |
49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.64967919 |
50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64105143 |
51 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.63804156 |
52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62468456 |
53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.59554275 |
54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59209160 |
55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.59208131 |
56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57799465 |
57 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.56751199 |
58 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.56727540 |
59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56308726 |
60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55160598 |
61 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.54980982 |
62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.54964554 |
63 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.54570934 |
64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52657061 |
65 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.51598242 |
66 | MYC_22102868_ChIP-Seq_BL_Human | 1.51515142 |
67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50953883 |
68 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50496154 |
69 | MYB_26560356_Chip-Seq_TH2_Human | 1.49111100 |
70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48509742 |
71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47314547 |
72 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46833908 |
73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.46176074 |
74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.46174902 |
75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.46174902 |
76 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.44621023 |
77 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43823211 |
78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43814940 |
79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42822879 |
80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.42750062 |
81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.40803122 |
82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40645610 |
83 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.39949621 |
84 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38442400 |
85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.38355337 |
86 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37134364 |
87 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36831674 |
88 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36630362 |
89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35941584 |
90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34176620 |
91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33606953 |
92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31920534 |
93 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31253906 |
94 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30834858 |
95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30820585 |
96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30732612 |
97 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.30695996 |
98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.30608606 |
99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30504928 |
100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30373224 |
101 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.29189863 |
102 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.28917719 |
103 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28266572 |
104 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.28072805 |
105 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27582183 |
106 | CJUN_26792858_Chip-Seq_BT549_Human | 1.27551216 |
107 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27450751 |
108 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27330017 |
109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26668694 |
110 | MAF_26560356_Chip-Seq_TH1_Human | 1.25637022 |
111 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.25269167 |
112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24728495 |
113 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.23865833 |
114 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23853128 |
115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23702274 |
116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23550677 |
117 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23230879 |
118 | MYB_26560356_Chip-Seq_TH1_Human | 1.21667307 |
119 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.21309219 |
120 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20980267 |
121 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.19533106 |
122 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19376484 |
123 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18731993 |
124 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18266268 |
125 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17939608 |
126 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.17508427 |
127 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16637919 |
128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16521523 |
129 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15887936 |
130 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15234215 |
131 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15178745 |
132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15033661 |
133 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14696255 |
134 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14696255 |
135 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14615773 |
136 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.14205931 |
137 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12903913 |
138 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.12781550 |
139 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.12340858 |
140 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11991106 |
141 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.11662430 |
142 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11205462 |
143 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10759441 |
144 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10066443 |
145 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10066443 |
146 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09761990 |
147 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09353337 |
148 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08535266 |
149 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08449736 |
150 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07871475 |
151 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07600474 |
152 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06742129 |
153 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06701198 |
154 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06102067 |
155 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.05956936 |
156 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05729597 |
157 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.05489597 |
158 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05070318 |
159 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04466941 |
160 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.04234142 |
161 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02785586 |
162 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.01346599 |
163 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01123183 |
164 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98892569 |
165 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95796976 |
166 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95011479 |
167 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94779219 |
168 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94208651 |
169 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93720851 |
170 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88908776 |
171 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88166800 |
172 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88166800 |
173 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.87192300 |
174 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86917499 |
175 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86641949 |
176 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86610051 |
177 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.85725703 |
178 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85029585 |
179 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84808548 |
180 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84073612 |
181 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83956564 |
182 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.80133642 |
183 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79473818 |
184 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79063155 |
185 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.77468454 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003191_abnormal_cellular_cholesterol | 3.77739281 |
2 | MP0006082_CNS_inflammation | 3.37747938 |
3 | MP0008057_abnormal_DNA_replication | 3.29655277 |
4 | MP0003890_abnormal_embryonic-extraembry | 3.27027626 |
5 | MP0005058_abnormal_lysosome_morphology | 3.03508343 |
6 | MP0005171_absent_coat_pigmentation | 2.95494241 |
7 | MP0000569_abnormal_digit_pigmentation | 2.87145011 |
8 | MP0003300_gastrointestinal_ulcer | 2.78492855 |
9 | MP0003172_abnormal_lysosome_physiology | 2.76048900 |
10 | MP0001835_abnormal_antigen_presentation | 2.67733982 |
11 | MP0002102_abnormal_ear_morphology | 2.53627718 |
12 | MP0005275_abnormal_skin_tensile | 2.46827143 |
13 | MP0003303_peritoneal_inflammation | 2.46658199 |
14 | MP0010030_abnormal_orbit_morphology | 2.39362632 |
15 | MP0002938_white_spotting | 2.37143019 |
16 | MP0005671_abnormal_response_to | 2.25048274 |
17 | MP0003937_abnormal_limbs/digits/tail_de | 2.22592289 |
18 | MP0010094_abnormal_chromosome_stability | 2.17114779 |
19 | MP0000372_irregular_coat_pigmentation | 2.14207031 |
20 | MP0003436_decreased_susceptibility_to | 2.09960804 |
21 | MP0001293_anophthalmia | 2.04266102 |
22 | MP0002419_abnormal_innate_immunity | 2.04252588 |
23 | MP0002233_abnormal_nose_morphology | 2.02175097 |
24 | MP0005464_abnormal_platelet_physiology | 1.96898484 |
25 | MP0008438_abnormal_cutaneous_collagen | 1.93818597 |
26 | MP0009278_abnormal_bone_marrow | 1.91986940 |
27 | MP0002928_abnormal_bile_duct | 1.90848804 |
28 | MP0005076_abnormal_cell_differentiation | 1.90026695 |
29 | MP0005257_abnormal_intraocular_pressure | 1.86460739 |
30 | MP0009053_abnormal_anal_canal | 1.81538314 |
31 | MP0003252_abnormal_bile_duct | 1.80301049 |
32 | MP0003941_abnormal_skin_development | 1.76693003 |
33 | MP0002452_abnormal_antigen_presenting | 1.75779527 |
34 | MP0002234_abnormal_pharynx_morphology | 1.73495264 |
35 | MP0001286_abnormal_eye_development | 1.71970294 |
36 | MP0005408_hypopigmentation | 1.70446408 |
37 | MP0003755_abnormal_palate_morphology | 1.67574417 |
38 | MP0001533_abnormal_skeleton_physiology | 1.65238889 |
39 | MP0000778_abnormal_nervous_system | 1.64579903 |
40 | MP0001299_abnormal_eye_distance/ | 1.62747038 |
41 | MP0004957_abnormal_blastocyst_morpholog | 1.53581478 |
42 | MP0002751_abnormal_autonomic_nervous | 1.52708781 |
43 | MP0003183_abnormal_peptide_metabolism | 1.51569369 |
44 | MP0005000_abnormal_immune_tolerance | 1.50624088 |
45 | MP0001800_abnormal_humoral_immune | 1.50563586 |
46 | MP0003136_yellow_coat_color | 1.48931748 |
47 | MP0001324_abnormal_eye_pigmentation | 1.48616136 |
48 | MP0002998_abnormal_bone_remodeling | 1.48460533 |
49 | MP0008058_abnormal_DNA_repair | 1.47418204 |
50 | MP0000428_abnormal_craniofacial_morphol | 1.46808207 |
51 | MP0003279_aneurysm | 1.46409658 |
52 | MP0000432_abnormal_head_morphology | 1.46270971 |
53 | MP0000465_gastrointestinal_hemorrhage | 1.44506421 |
54 | MP0001177_atelectasis | 1.43921922 |
55 | MP0003077_abnormal_cell_cycle | 1.42312643 |
56 | MP0001915_intracranial_hemorrhage | 1.41976046 |
57 | MP0002723_abnormal_immune_serum | 1.41432505 |
58 | MP0003935_abnormal_craniofacial_develop | 1.40849897 |
59 | MP0006054_spinal_hemorrhage | 1.40088615 |
60 | MP0003566_abnormal_cell_adhesion | 1.39187115 |
61 | MP0006292_abnormal_olfactory_placode | 1.38867190 |
62 | MP0002396_abnormal_hematopoietic_system | 1.38763021 |
63 | MP0000647_abnormal_sebaceous_gland | 1.38379238 |
64 | MP0003119_abnormal_digestive_system | 1.38157202 |
65 | MP0002148_abnormal_hypersensitivity_rea | 1.37260041 |
66 | MP0003385_abnormal_body_wall | 1.37131473 |
67 | MP0010352_gastrointestinal_tract_polyps | 1.36969963 |
68 | MP0001851_eye_inflammation | 1.36932762 |
69 | MP0001819_abnormal_immune_cell | 1.36842890 |
70 | MP0002166_altered_tumor_susceptibility | 1.36209364 |
71 | MP0003121_genomic_imprinting | 1.35928806 |
72 | MP0009703_decreased_birth_body | 1.32950504 |
73 | MP0002420_abnormal_adaptive_immunity | 1.32901131 |
74 | MP0008932_abnormal_embryonic_tissue | 1.30006444 |
75 | MP0000537_abnormal_urethra_morphology | 1.28854088 |
76 | MP0002111_abnormal_tail_morphology | 1.25609539 |
77 | MP0008007_abnormal_cellular_replicative | 1.24565274 |
78 | MP0000015_abnormal_ear_pigmentation | 1.24562912 |
79 | MP0002084_abnormal_developmental_patter | 1.23675900 |
80 | MP0004272_abnormal_basement_membrane | 1.23029691 |
81 | MP0010307_abnormal_tumor_latency | 1.22483289 |
82 | MP0003705_abnormal_hypodermis_morpholog | 1.21020047 |
83 | MP0005367_renal/urinary_system_phenotyp | 1.20667957 |
84 | MP0000516_abnormal_urinary_system | 1.20667957 |
85 | MP0004808_abnormal_hematopoietic_stem | 1.20547328 |
86 | MP0005409_darkened_coat_color | 1.18924554 |
87 | MP0003690_abnormal_glial_cell | 1.18910183 |
88 | MP0003195_calcinosis | 1.16057674 |
89 | MP0005390_skeleton_phenotype | 1.15564063 |
90 | MP0005391_vision/eye_phenotype | 1.15221171 |
91 | MP0008877_abnormal_DNA_methylation | 1.15182953 |
92 | MP0004134_abnormal_chest_morphology | 1.14888796 |
93 | MP0003075_altered_response_to | 1.14872387 |
94 | MP0005387_immune_system_phenotype | 1.13497501 |
95 | MP0001790_abnormal_immune_system | 1.13497501 |
96 | MP0004185_abnormal_adipocyte_glucose | 1.11757676 |
97 | * MP0000767_abnormal_smooth_muscle | 1.10778796 |
98 | * MP0002085_abnormal_embryonic_tissue | 1.10454109 |
99 | MP0005025_abnormal_response_to | 1.09765766 |
100 | MP0001845_abnormal_inflammatory_respons | 1.08433771 |
101 | MP0005023_abnormal_wound_healing | 1.07778843 |
102 | MP0002109_abnormal_limb_morphology | 1.07491096 |
103 | MP0002405_respiratory_system_inflammati | 1.07331801 |
104 | MP0005187_abnormal_penis_morphology | 1.07200538 |
105 | MP0003567_abnormal_fetal_cardiomyocyte | 1.07132472 |
106 | MP0009250_abnormal_appendicular_skeleto | 1.06672074 |
107 | MP0000733_abnormal_muscle_development | 1.06647740 |
108 | MP0003111_abnormal_nucleus_morphology | 1.06390364 |
109 | MP0008004_abnormal_stomach_pH | 1.06032205 |
110 | MP0002092_abnormal_eye_morphology | 1.05190281 |
111 | MP0000427_abnormal_hair_cycle | 1.04639355 |
112 | MP0005174_abnormal_tail_pigmentation | 1.03986223 |
113 | MP0003950_abnormal_plasma_membrane | 1.03982460 |
114 | MP0002933_joint_inflammation | 1.01970508 |
115 | MP0003828_pulmonary_edema | 1.01612664 |
116 | MP0000716_abnormal_immune_system | 1.01246842 |
117 | MP0003448_altered_tumor_morphology | 1.00178691 |
118 | MP0000685_abnormal_immune_system | 1.00116831 |
119 | MP0005197_abnormal_uvea_morphology | 0.99802399 |
120 | MP0000343_altered_response_to | 0.99732043 |
121 | MP0009384_cardiac_valve_regurgitation | 0.98049847 |
122 | MP0002398_abnormal_bone_marrow | 0.96760951 |
123 | MP0002254_reproductive_system_inflammat | 0.96747635 |
124 | MP0002896_abnormal_bone_mineralization | 0.96575017 |
125 | MP0001853_heart_inflammation | 0.96252569 |
126 | MP0000383_abnormal_hair_follicle | 0.95657966 |
127 | MP0002095_abnormal_skin_pigmentation | 0.95339384 |
128 | MP0005166_decreased_susceptibility_to | 0.94876716 |
129 | MP0005167_abnormal_blood-brain_barrier | 0.94155382 |
130 | MP0005670_abnormal_white_adipose | 0.93693234 |
131 | MP0003693_abnormal_embryo_hatching | 0.93242805 |
132 | MP0002006_tumorigenesis | 0.93031695 |
133 | MP0009672_abnormal_birth_weight | 0.93013898 |
134 | MP0003942_abnormal_urinary_system | 0.92819665 |
135 | MP0005397_hematopoietic_system_phenotyp | 0.92225531 |
136 | MP0001545_abnormal_hematopoietic_system | 0.92225531 |
137 | MP0000762_abnormal_tongue_morphology | 0.92161581 |
138 | MP0003795_abnormal_bone_structure | 0.92150639 |
139 | MP0001879_abnormal_lymphatic_vessel | 0.92030643 |
140 | MP0010368_abnormal_lymphatic_system | 0.91723280 |
141 | MP0001849_ear_inflammation | 0.91550735 |
142 | MP0002168_other_aberrant_phenotype | 0.91529314 |
143 | MP0000049_abnormal_middle_ear | 0.90973582 |
144 | MP0003724_increased_susceptibility_to | 0.90922598 |
145 | MP0003091_abnormal_cell_migration | 0.90496819 |
146 | MP0005508_abnormal_skeleton_morphology | 0.90331968 |
147 | MP0004197_abnormal_fetal_growth/weight/ | 0.89906478 |
148 | MP0000689_abnormal_spleen_morphology | 0.89822717 |
149 | MP0000371_diluted_coat_color | 0.88726156 |
150 | MP0003938_abnormal_ear_development | 0.88278851 |
151 | MP0004510_myositis | 0.87872877 |
152 | MP0005248_abnormal_Harderian_gland | 0.87314125 |
153 | MP0000249_abnormal_blood_vessel | 0.87128185 |
154 | MP0002009_preneoplasia | 0.87091073 |
155 | MP0005253_abnormal_eye_physiology | 0.86925939 |
156 | MP0002282_abnormal_trachea_morphology | 0.86893397 |
157 | MP0008469_abnormal_protein_level | 0.86762610 |
158 | MP0004883_abnormal_blood_vessel | 0.85800101 |
159 | MP0010678_abnormal_skin_adnexa | 0.85689573 |
160 | MP0010234_abnormal_vibrissa_follicle | 0.85160383 |
161 | MP0004947_skin_inflammation | 0.84770166 |
162 | MP0002116_abnormal_craniofacial_bone | 0.84264278 |
163 | * MP0001672_abnormal_embryogenesis/_devel | 0.83402107 |
164 | * MP0005380_embryogenesis_phenotype | 0.83402107 |
165 | MP0010155_abnormal_intestine_physiology | 0.83296051 |
166 | MP0002277_abnormal_respiratory_mucosa | 0.83254643 |
167 | MP0002115_abnormal_skeleton_extremities | 0.83028763 |
168 | MP0009697_abnormal_copulation | 0.82957023 |
169 | MP0005503_abnormal_tendon_morphology | 0.82731420 |
170 | MP0002697_abnormal_eye_size | 0.82686098 |
171 | MP0009840_abnormal_foam_cell | 0.82026542 |
172 | MP0005395_other_phenotype | 0.81933935 |
173 | MP0003045_fibrosis | 0.81923869 |
174 | MP0003122_maternal_imprinting | 0.80826689 |
175 | MP0001186_pigmentation_phenotype | 0.80033513 |
176 | MP0002722_abnormal_immune_system | 0.79985453 |
177 | MP0003283_abnormal_digestive_organ | 0.79839894 |
178 | MP0002429_abnormal_blood_cell | 0.79691392 |
179 | * MP0001697_abnormal_embryo_size | 0.79366133 |
180 | MP0005193_abnormal_anterior_eye | 0.79245388 |
181 | MP0002113_abnormal_skeleton_development | 0.79092533 |
182 | * MP0003861_abnormal_nervous_system | 0.79057405 |
183 | * MP0002088_abnormal_embryonic_growth/wei | 0.78843415 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 7.02165261 |
2 | Glomerulonephritis (HP:0000099) | 6.04597346 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.88775250 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.88775250 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.88775250 |
6 | Hematochezia (HP:0002573) | 4.41796229 |
7 | Complement deficiency (HP:0004431) | 4.38483832 |
8 | Disinhibition (HP:0000734) | 4.05744670 |
9 | Increased cerebral lipofuscin (HP:0011813) | 3.91184243 |
10 | Recurrent abscess formation (HP:0002722) | 3.75244580 |
11 | Recurrent bacterial skin infections (HP:0005406) | 3.63949845 |
12 | Volvulus (HP:0002580) | 3.62325160 |
13 | Retinal atrophy (HP:0001105) | 3.62018787 |
14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.54958947 |
15 | Abnormality of complement system (HP:0005339) | 3.48546551 |
16 | Urethral obstruction (HP:0000796) | 3.44140798 |
17 | Dysostosis multiplex (HP:0000943) | 3.43703178 |
18 | Eczematoid dermatitis (HP:0000976) | 3.33876647 |
19 | Nephritis (HP:0000123) | 3.25739453 |
20 | Aqueductal stenosis (HP:0002410) | 3.18135596 |
21 | Bifid tongue (HP:0010297) | 3.06298833 |
22 | Mutism (HP:0002300) | 2.97499281 |
23 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.89317194 |
24 | Mucopolysacchariduria (HP:0008155) | 2.89317194 |
25 | Abnormality of chromosome stability (HP:0003220) | 2.84848193 |
26 | Spondylolisthesis (HP:0003302) | 2.83384988 |
27 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.83052184 |
28 | Chronic diarrhea (HP:0002028) | 2.80978391 |
29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.80876985 |
30 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.80876985 |
31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.80876985 |
32 | Abnormal lung lobation (HP:0002101) | 2.71659484 |
33 | Chromsome breakage (HP:0040012) | 2.70097781 |
34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.67181666 |
35 | Rhabdomyosarcoma (HP:0002859) | 2.66209459 |
36 | Vacuolated lymphocytes (HP:0001922) | 2.65188731 |
37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64951957 |
38 | Agnosia (HP:0010524) | 2.64015270 |
39 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.50363943 |
40 | Absent frontal sinuses (HP:0002688) | 2.42075958 |
41 | Upper motor neuron abnormality (HP:0002127) | 2.37623907 |
42 | * Arterial tortuosity (HP:0005116) | 2.35455020 |
43 | Embryonal renal neoplasm (HP:0011794) | 2.34439326 |
44 | Septo-optic dysplasia (HP:0100842) | 2.32599615 |
45 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.30151439 |
46 | * Cerebral aneurysm (HP:0004944) | 2.28415473 |
47 | Papillary thyroid carcinoma (HP:0002895) | 2.27721375 |
48 | Abnormality of the ischium (HP:0003174) | 2.26981987 |
49 | Inappropriate behavior (HP:0000719) | 2.25793706 |
50 | Small hand (HP:0200055) | 2.24376190 |
51 | Axonal loss (HP:0003447) | 2.24191296 |
52 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.22536329 |
53 | Myocardial infarction (HP:0001658) | 2.21928304 |
54 | Orthostatic hypotension (HP:0001278) | 2.21579031 |
55 | Long clavicles (HP:0000890) | 2.17246401 |
56 | Subacute progressive viral hepatitis (HP:0006572) | 2.16308183 |
57 | Preaxial foot polydactyly (HP:0001841) | 2.15744867 |
58 | Hypoplastic pelvis (HP:0008839) | 2.15332700 |
59 | Deep philtrum (HP:0002002) | 2.13565169 |
60 | * Mitral valve prolapse (HP:0001634) | 2.13486071 |
61 | * Aortic aneurysm (HP:0004942) | 2.12125627 |
62 | Meckel diverticulum (HP:0002245) | 2.10717409 |
63 | Colitis (HP:0002583) | 2.09166187 |
64 | Short 4th metacarpal (HP:0010044) | 2.08651510 |
65 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.08651510 |
66 | Osteolytic defects of the hand bones (HP:0009699) | 2.08440350 |
67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08440350 |
68 | Ependymoma (HP:0002888) | 2.08352487 |
69 | Pathologic fracture (HP:0002756) | 2.07933237 |
70 | Intestinal fistula (HP:0100819) | 2.07170031 |
71 | Cardiomegaly (HP:0001640) | 2.06455999 |
72 | * Disproportionate tall stature (HP:0001519) | 2.05568199 |
73 | Recurrent skin infections (HP:0001581) | 2.04366795 |
74 | Renal hypoplasia (HP:0000089) | 2.02531772 |
75 | Abnormality of the ileum (HP:0001549) | 2.01088588 |
76 | Rectal fistula (HP:0100590) | 2.00121682 |
77 | Rectovaginal fistula (HP:0000143) | 2.00121682 |
78 | Thyroiditis (HP:0100646) | 1.99905476 |
79 | Astrocytoma (HP:0009592) | 1.98528508 |
80 | Abnormality of the astrocytes (HP:0100707) | 1.98528508 |
81 | Glioma (HP:0009733) | 1.98011314 |
82 | Pulmonic stenosis (HP:0001642) | 1.97551158 |
83 | Hemivertebrae (HP:0002937) | 1.97266378 |
84 | Abnormality of macrophages (HP:0004311) | 1.97057023 |
85 | Syringomyelia (HP:0003396) | 1.96953192 |
86 | Spinal cord lesions (HP:0100561) | 1.96953192 |
87 | Abnormality of the duodenum (HP:0002246) | 1.96861898 |
88 | Camptodactyly of toe (HP:0001836) | 1.96299725 |
89 | * Vascular tortuosity (HP:0004948) | 1.95242926 |
90 | Cutaneous finger syndactyly (HP:0010554) | 1.94805240 |
91 | Anophthalmia (HP:0000528) | 1.93631612 |
92 | Spontaneous hematomas (HP:0007420) | 1.93142515 |
93 | Hypoplastic labia majora (HP:0000059) | 1.92788149 |
94 | Small intestinal stenosis (HP:0012848) | 1.92517164 |
95 | Duodenal stenosis (HP:0100867) | 1.92517164 |
96 | Neoplasm of striated muscle (HP:0009728) | 1.92397447 |
97 | Mild short stature (HP:0003502) | 1.92144567 |
98 | Morphological abnormality of the middle ear (HP:0008609) | 1.91815976 |
99 | Myositis (HP:0100614) | 1.91455351 |
100 | Thickened calvaria (HP:0002684) | 1.90953067 |
101 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.90774154 |
102 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.90369468 |
103 | Overgrowth (HP:0001548) | 1.90267792 |
104 | Midline defect of the nose (HP:0004122) | 1.90150014 |
105 | Neuronal loss in central nervous system (HP:0002529) | 1.89581049 |
106 | * Soft skin (HP:0000977) | 1.89556676 |
107 | Mesomelia (HP:0003027) | 1.88936247 |
108 | Abnormality of the septum pellucidum (HP:0007375) | 1.87966829 |
109 | Severe Myopia (HP:0011003) | 1.86655416 |
110 | Genital tract atresia (HP:0001827) | 1.85838754 |
111 | Cortical dysplasia (HP:0002539) | 1.85088885 |
112 | Vaginal fistula (HP:0004320) | 1.84978806 |
113 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.84587894 |
114 | Apathy (HP:0000741) | 1.84478341 |
115 | * Aortic dissection (HP:0002647) | 1.84380147 |
116 | Fibular hypoplasia (HP:0003038) | 1.83985376 |
117 | Myelomeningocele (HP:0002475) | 1.83263494 |
118 | Shallow orbits (HP:0000586) | 1.83163204 |
119 | Gingivitis (HP:0000230) | 1.83025546 |
120 | Abnormality of the fingertips (HP:0001211) | 1.82854236 |
121 | Large earlobe (HP:0009748) | 1.81942231 |
122 | Bone pain (HP:0002653) | 1.81633726 |
123 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.79658590 |
124 | Abnormality of the peritoneum (HP:0002585) | 1.78917798 |
125 | Oligodactyly (hands) (HP:0001180) | 1.78551950 |
126 | Abnormality of the antihelix (HP:0009738) | 1.78418017 |
127 | Basal ganglia calcification (HP:0002135) | 1.78011639 |
128 | Cystic hygroma (HP:0000476) | 1.77855356 |
129 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.77420106 |
130 | Dyschromatopsia (HP:0007641) | 1.76859377 |
131 | Diminished motivation (HP:0000745) | 1.76326652 |
132 | Periodontitis (HP:0000704) | 1.75912997 |
133 | Vaginal atresia (HP:0000148) | 1.75851096 |
134 | Asymmetry of the thorax (HP:0001555) | 1.75725836 |
135 | Dandy-Walker malformation (HP:0001305) | 1.75689737 |
136 | Recurrent fungal infections (HP:0002841) | 1.75030253 |
137 | Labial hypoplasia (HP:0000066) | 1.74952480 |
138 | Ectopic kidney (HP:0000086) | 1.74398848 |
139 | Intestinal atresia (HP:0011100) | 1.74208937 |
140 | Leiomyosarcoma (HP:0100243) | 1.74196050 |
141 | Uterine leiomyosarcoma (HP:0002891) | 1.74196050 |
142 | Vitreoretinal degeneration (HP:0000655) | 1.74160744 |
143 | Absent septum pellucidum (HP:0001331) | 1.73998849 |
144 | Arterial thrombosis (HP:0004420) | 1.73937611 |
145 | Abnormality of the labia minora (HP:0012880) | 1.73334920 |
146 | Curly hair (HP:0002212) | 1.73273399 |
147 | Abnormality of the labia majora (HP:0012881) | 1.72663981 |
148 | Long nose (HP:0003189) | 1.72449072 |
149 | Bladder neoplasm (HP:0009725) | 1.71633577 |
150 | Bladder carcinoma (HP:0002862) | 1.71633577 |
151 | Renal duplication (HP:0000075) | 1.71539609 |
152 | Medulloblastoma (HP:0002885) | 1.71331598 |
153 | Narrow palate (HP:0000189) | 1.70796349 |
154 | Thick nail (HP:0001805) | 1.70088995 |
155 | Increased density of long bones (HP:0006392) | 1.68408323 |
156 | Gastrointestinal atresia (HP:0002589) | 1.68362127 |
157 | Colon cancer (HP:0003003) | 1.67853924 |
158 | Thyroid carcinoma (HP:0002890) | 1.67610460 |
159 | Hypoplastic female external genitalia (HP:0012815) | 1.67458310 |
160 | Abnormality of the 4th metacarpal (HP:0010012) | 1.67333127 |
161 | Chorioretinal atrophy (HP:0000533) | 1.66847391 |
162 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.66071993 |
163 | Neoplasm of the adrenal cortex (HP:0100641) | 1.65997670 |
164 | Anal stenosis (HP:0002025) | 1.64861126 |
165 | Gastrointestinal carcinoma (HP:0002672) | 1.64579853 |
166 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.64579853 |
167 | Peripheral demyelination (HP:0011096) | 1.64191716 |
168 | Abnormal platelet function (HP:0011869) | 1.64071746 |
169 | Impaired platelet aggregation (HP:0003540) | 1.64071746 |
170 | Broad ribs (HP:0000885) | 1.63608648 |
171 | Coarse hair (HP:0002208) | 1.63395919 |
172 | Inflammation of the large intestine (HP:0002037) | 1.63340231 |
173 | Eosinophilia (HP:0001880) | 1.62849837 |
174 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.62340190 |
175 | Absent eyebrow (HP:0002223) | 1.61468284 |
176 | Neoplasm of the oral cavity (HP:0100649) | 1.60995537 |
177 | Interstitial pulmonary disease (HP:0006530) | 1.60994860 |
178 | Osteomyelitis (HP:0002754) | 1.60962687 |
179 | Hypoplastic ischia (HP:0003175) | 1.60707061 |
180 | Cupped ear (HP:0000378) | 1.59911970 |
181 | Hyperacusis (HP:0010780) | 1.58967868 |
182 | Cutaneous syndactyly (HP:0012725) | 1.58860925 |
183 | Abnormal auditory evoked potentials (HP:0006958) | 1.58096132 |
184 | Clubbing of toes (HP:0100760) | 1.57469274 |
185 | Broad long bones (HP:0005622) | 1.56837053 |
186 | Disproportionate short-trunk short stature (HP:0003521) | 1.56596456 |
187 | Drooling (HP:0002307) | 1.56559408 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAPK15 | 4.50395882 |
2 | * TGFBR2 | 4.22332607 |
3 | TRIM28 | 3.37407397 |
4 | GRK7 | 3.28003526 |
5 | CSF1R | 3.27529353 |
6 | TNIK | 3.03533181 |
7 | MKNK2 | 2.97146011 |
8 | WNK3 | 2.87878859 |
9 | CAMK1D | 2.81373038 |
10 | ACVR1B | 2.54950920 |
11 | BRSK2 | 2.38534965 |
12 | EIF2AK3 | 2.29850215 |
13 | BCR | 2.25873174 |
14 | PAK4 | 2.17634205 |
15 | WEE1 | 2.15925732 |
16 | CAMK1G | 2.15164867 |
17 | TYK2 | 2.14762482 |
18 | PLK3 | 2.09978566 |
19 | PKN2 | 2.08526266 |
20 | PDK2 | 1.89061475 |
21 | PLK4 | 1.84261272 |
22 | BUB1 | 1.84160464 |
23 | CASK | 1.82758852 |
24 | PLK2 | 1.80031331 |
25 | ERBB3 | 1.79773315 |
26 | CDK6 | 1.75977754 |
27 | STK10 | 1.75391786 |
28 | ITK | 1.74369895 |
29 | SRPK1 | 1.70665110 |
30 | NEK9 | 1.69782189 |
31 | PTK6 | 1.69234004 |
32 | TAF1 | 1.65319133 |
33 | PNCK | 1.63037688 |
34 | STK38L | 1.61961333 |
35 | IRAK4 | 1.60896491 |
36 | PBK | 1.58406602 |
37 | BMPR1B | 1.57967207 |
38 | MAP3K14 | 1.52510241 |
39 | CDK12 | 1.52200425 |
40 | MAP3K10 | 1.51351441 |
41 | TBK1 | 1.50757058 |
42 | CLK1 | 1.44884637 |
43 | JAK1 | 1.43795993 |
44 | EEF2K | 1.43209795 |
45 | LATS1 | 1.42246236 |
46 | TTK | 1.39003934 |
47 | TSSK6 | 1.35253725 |
48 | CDC7 | 1.33405838 |
49 | STK3 | 1.32556553 |
50 | FGFR3 | 1.31150144 |
51 | FGFR2 | 1.29407137 |
52 | PDGFRA | 1.29340925 |
53 | STK39 | 1.26931056 |
54 | ZAP70 | 1.26733112 |
55 | RIPK4 | 1.23492779 |
56 | VRK1 | 1.21571233 |
57 | RPS6KA4 | 1.19128198 |
58 | HCK | 1.13984368 |
59 | CDK3 | 1.09239303 |
60 | NLK | 1.08795988 |
61 | EPHB2 | 1.08490271 |
62 | CHUK | 1.06307960 |
63 | PAK2 | 1.04894089 |
64 | PLK1 | 1.01407899 |
65 | CSK | 1.00801404 |
66 | NUAK1 | 1.00218781 |
67 | MAP4K1 | 1.00134972 |
68 | TRIB3 | 0.98822112 |
69 | INSRR | 0.97731242 |
70 | ERN1 | 0.96735275 |
71 | EPHA4 | 0.96313477 |
72 | KSR1 | 0.95314237 |
73 | ZAK | 0.95303619 |
74 | JAK2 | 0.94422140 |
75 | STK24 | 0.91793344 |
76 | NEK1 | 0.91727223 |
77 | FGFR4 | 0.90554181 |
78 | YES1 | 0.89955432 |
79 | OXSR1 | 0.89615676 |
80 | ERBB4 | 0.89580963 |
81 | PDGFRB | 0.87965137 |
82 | EIF2AK1 | 0.87940857 |
83 | IKBKB | 0.87701010 |
84 | DYRK3 | 0.86991372 |
85 | BLK | 0.86741760 |
86 | SIK1 | 0.86654309 |
87 | LYN | 0.86240216 |
88 | KIT | 0.85621753 |
89 | MAP3K3 | 0.85557505 |
90 | MAP2K3 | 0.85180529 |
91 | AKT3 | 0.85144517 |
92 | IRAK3 | 0.84841491 |
93 | CDK9 | 0.83791860 |
94 | BRD4 | 0.82238068 |
95 | MARK3 | 0.81508640 |
96 | RIPK1 | 0.78379859 |
97 | SCYL2 | 0.73810799 |
98 | IGF1R | 0.73559269 |
99 | ATM | 0.73434483 |
100 | SGK2 | 0.73083534 |
101 | LCK | 0.72090921 |
102 | GSK3A | 0.71344832 |
103 | TXK | 0.71246944 |
104 | MATK | 0.70393316 |
105 | EPHA3 | 0.69592248 |
106 | MAPKAPK2 | 0.69583628 |
107 | SIK2 | 0.69195397 |
108 | JAK3 | 0.69178586 |
109 | MAP3K4 | 0.67772043 |
110 | MELK | 0.67348310 |
111 | FGR | 0.67074437 |
112 | LATS2 | 0.65618008 |
113 | NEK2 | 0.65425521 |
114 | BTK | 0.65173594 |
115 | CAMK4 | 0.64428883 |
116 | FRK | 0.63816816 |
117 | MAPK7 | 0.63736406 |
118 | TTN | 0.62846644 |
119 | MAP3K13 | 0.62228815 |
120 | PAK3 | 0.62133635 |
121 | EGFR | 0.61716549 |
122 | FER | 0.60550775 |
123 | ATR | 0.59437218 |
124 | EIF2AK2 | 0.59148948 |
125 | CAMKK2 | 0.58854969 |
126 | MAPK12 | 0.58581919 |
127 | CSNK1G1 | 0.58202271 |
128 | MET | 0.57480638 |
129 | MST4 | 0.57264998 |
130 | BRSK1 | 0.56746037 |
131 | ICK | 0.56534989 |
132 | EPHB1 | 0.56268182 |
133 | SIK3 | 0.56038730 |
134 | DDR2 | 0.55498582 |
135 | PRKCE | 0.54575662 |
136 | PIK3CG | 0.52959957 |
137 | DMPK | 0.52426885 |
138 | FGFR1 | 0.52097138 |
139 | TGFBR1 | 0.52095484 |
140 | MTOR | 0.51655842 |
141 | AURKB | 0.51230452 |
142 | MKNK1 | 0.51198479 |
143 | ERBB2 | 0.51178312 |
144 | CHEK2 | 0.50777633 |
145 | INSR | 0.49460641 |
146 | MOS | 0.48144864 |
147 | SGK3 | 0.48026415 |
148 | DYRK1B | 0.47961586 |
149 | TEC | 0.47376623 |
150 | FLT3 | 0.46667296 |
151 | ADRBK2 | 0.46581667 |
152 | STK4 | 0.45416750 |
153 | TRPM7 | 0.45336905 |
154 | MINK1 | 0.43836046 |
155 | CSNK1G2 | 0.43469747 |
156 | IRAK2 | 0.43082074 |
157 | STK11 | 0.42063626 |
158 | ROCK2 | 0.40153620 |
159 | ROCK1 | 0.37007832 |
160 | DYRK1A | 0.35953082 |
161 | NEK6 | 0.35939497 |
162 | ADRBK1 | 0.35244918 |
163 | PIK3CA | 0.34630802 |
164 | MAP3K2 | 0.34621594 |
165 | MAPK13 | 0.34247483 |
166 | CHEK1 | 0.33036130 |
167 | ABL1 | 0.32613318 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 4.49915523 |
2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.60486694 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.52420255 |
4 | Mismatch repair_Homo sapiens_hsa03430 | 2.79109916 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.71406915 |
6 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.65024307 |
7 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.56822285 |
8 | Cell cycle_Homo sapiens_hsa04110 | 2.48269943 |
9 | Homologous recombination_Homo sapiens_hsa03440 | 2.41415304 |
10 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35062069 |
11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.25450861 |
12 | Lysosome_Homo sapiens_hsa04142 | 2.25398885 |
13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.23439831 |
14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.20074464 |
15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16588591 |
16 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.99554515 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.90465549 |
18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.88924986 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84581395 |
20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.78036340 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77513967 |
22 | Protein export_Homo sapiens_hsa03060 | 1.77480794 |
23 | Pertussis_Homo sapiens_hsa05133 | 1.76040309 |
24 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 1.73907505 |
25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67330328 |
26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61302670 |
27 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60427290 |
28 | RNA transport_Homo sapiens_hsa03013 | 1.60367595 |
29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59970399 |
30 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.58260415 |
31 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.53599465 |
32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51292422 |
33 | Legionellosis_Homo sapiens_hsa05134 | 1.47494182 |
34 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.45072805 |
35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40780764 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.35930005 |
37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33448339 |
38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.32224428 |
39 | RNA degradation_Homo sapiens_hsa03018 | 1.32150613 |
40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.31204494 |
41 | Axon guidance_Homo sapiens_hsa04360 | 1.30447689 |
42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.30050113 |
43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27173895 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26784700 |
45 | Measles_Homo sapiens_hsa05162 | 1.26120882 |
46 | Prion diseases_Homo sapiens_hsa05020 | 1.23689168 |
47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.23516027 |
48 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.22201745 |
49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21534390 |
50 | Influenza A_Homo sapiens_hsa05164 | 1.20707328 |
51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19473720 |
52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17523804 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15537756 |
54 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.13913344 |
55 | * Adherens junction_Homo sapiens_hsa04520 | 1.13190539 |
56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12663827 |
57 | * Colorectal cancer_Homo sapiens_hsa05210 | 1.10581220 |
58 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09310999 |
59 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08138931 |
60 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07160747 |
61 | DNA replication_Homo sapiens_hsa03030 | 1.06176035 |
62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04995767 |
63 | Apoptosis_Homo sapiens_hsa04210 | 1.04614088 |
64 | * Hepatitis B_Homo sapiens_hsa05161 | 1.03637405 |
65 | Malaria_Homo sapiens_hsa05144 | 1.02630133 |
66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.02195412 |
67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98947364 |
68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98678413 |
69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98572517 |
70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98487919 |
71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97185050 |
72 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.97025855 |
73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96285299 |
74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.95857738 |
75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95820915 |
76 | Platelet activation_Homo sapiens_hsa04611 | 0.95234125 |
77 | Melanogenesis_Homo sapiens_hsa04916 | 0.93157077 |
78 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91861414 |
79 | Phagosome_Homo sapiens_hsa04145 | 0.91677123 |
80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91341437 |
81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90760646 |
82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90327544 |
83 | Prostate cancer_Homo sapiens_hsa05215 | 0.90257045 |
84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88103708 |
85 | Focal adhesion_Homo sapiens_hsa04510 | 0.86925813 |
86 | Amoebiasis_Homo sapiens_hsa05146 | 0.84380421 |
87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84244127 |
88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83399936 |
89 | Tight junction_Homo sapiens_hsa04530 | 0.82101761 |
90 | Salmonella infection_Homo sapiens_hsa05132 | 0.81210646 |
91 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79404926 |
92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78615160 |
93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77871634 |
94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77527083 |
95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77386200 |
96 | Shigellosis_Homo sapiens_hsa05131 | 0.76364916 |
97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76131620 |
98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76077502 |
99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76058215 |
100 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.75782524 |
101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75661464 |
102 | Lysine degradation_Homo sapiens_hsa00310 | 0.74689800 |
103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73806262 |
104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73725277 |
105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.71984743 |
106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71236354 |
107 | Insulin resistance_Homo sapiens_hsa04931 | 0.70490991 |
108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70257818 |
109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69337401 |
110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67748677 |
111 | ABC transporters_Homo sapiens_hsa02010 | 0.67093698 |
112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66765766 |
113 | * TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66350566 |
114 | Glioma_Homo sapiens_hsa05214 | 0.65215276 |
115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65079751 |
116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.64795107 |
117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64371391 |
118 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63557624 |
119 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.62492482 |
120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62256784 |
121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61648069 |
122 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61280582 |
123 | * Endocytosis_Homo sapiens_hsa04144 | 0.61000721 |
124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60033515 |
125 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59188290 |
126 | Proteasome_Homo sapiens_hsa03050 | 0.58337941 |
127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58327288 |
128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57825027 |
129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57534543 |
130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57342584 |
131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56441984 |
132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55294520 |
133 | Hepatitis C_Homo sapiens_hsa05160 | 0.55127035 |
134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51828428 |
135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51566289 |
136 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51080413 |
137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47763761 |
138 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47669762 |
139 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47606580 |
140 | Melanoma_Homo sapiens_hsa05218 | 0.47406548 |
141 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45981074 |
142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45452548 |
143 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45355036 |
144 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.43234290 |
145 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43170792 |
146 | Phototransduction_Homo sapiens_hsa04744 | 0.39045035 |
147 | Gap junction_Homo sapiens_hsa04540 | 0.38180662 |
148 | Base excision repair_Homo sapiens_hsa03410 | 0.33312319 |
149 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30587451 |
150 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30555737 |
151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27828378 |
152 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26289462 |
153 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24604103 |
154 | Long-term depression_Homo sapiens_hsa04730 | 0.23764329 |
155 | Spliceosome_Homo sapiens_hsa03040 | 0.22559287 |
156 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22544396 |